U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Sec. 8 - Entire Registration
First Use: Nov-1998
First Use in Commerce: Nov-1998
| Name | Nicholas J. Licato JD PhD |
|---|---|
| Address | Nexgen Pharma, Inc. Suite 200 46 Corporate Park Irvine CA 92606 |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Feb-19-2002 | ASSIGNED TO EXAMINER | DOCKD | |
| Mar-08-2002 | EXAMINER'S AMENDMENT MAILED | CNEAF | |
| Mar-09-2002 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Jun-26-2002 | NOTICE OF PUBLICATION | NPUBO | |
| Jul-16-2002 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Aug-02-2002 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI | |
| Oct-08-2002 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Jul-04-2007 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | ASGNI | |
| Feb-21-2008 | TEAS SECTION 8 & 15 RECEIVED | E815I | |
| Feb-27-2008 | ASSIGNED TO PARALEGAL | PLGLA | |
| Mar-01-2008 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | C15AO | |
| Jun-18-2008 | CASE FILE IN TICRS | CFITO | |
| Jul-10-2012 | TEAS SECTION 8 & 9 RECEIVED | E89RI | |
| Jul-20-2012 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | APREA | |
| Jul-20-2012 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 89AGO | |
| Jul-20-2012 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | RNL1Q | |
| Jul-20-2012 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | NA89E | |
| Sep-02-2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Sep-02-2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Nov-11-2017 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | WOARI | |
| Nov-11-2017 | WITHDRAWAL OF ATTORNEY GRANTED | WOAGI | |
| Nov-21-2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Nov-21-2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Feb-03-2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | ASGNI | |
| Oct-08-2021 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | REM2E | |
| Apr-21-2023 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | CAEXO |